drugset / Trial / NCT06547437

Papaverine and Oxytocin vs Oxytocin Alone in Labor Induction

NCT06547437

Not yet recruiting 126 enrolled Western Galilee Hospital-Nahariya
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to evaluate the efficacy and safety of combining papaverine with oxytocin for labor induction compared to oxytocin alone

Timeline

Start
2024-09
Primary completion
2025-09
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Papaverine Small molecule 80 mg Intravenous

Indications

No indication recorded.